Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: A report of OPERATION study

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 834-839

  Wu, Zhiguo ^a   Chen, Jun ^a   Yuan, Chengmei ^a   Hong, Wu ^a   Peng, Daihui ^a   Zhang, Chen ^a   Cao, Lan ^a   Fang, Yiru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Anxious depression; Major depressive disorder; Remission; Treatment resistant depression

Indexed keywords

BUSPIRONE; MIRTAZAPINE; PAROXETINE; RISPERIDONE; THYROID HORMONE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADULT; ADVERSE OUTCOME; ANXIETY; ANXIETY DISORDER; ANXIOUS DEPRESSION; ARTICLE; CHINESE; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DSM-5; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REMISSION; SCORING SYSTEM; SECONDARY ANALYSIS; SOMATIZATION; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; UNSPECIFIED SIDE EFFECT;

ANXIOUS DEPRESSION; MAJOR DEPRESSIVE DISORDER; REMISSION; TREATMENT RESISTANT DEPRESSION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BUSPIRONE; CHINA; COMORBIDITY; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; REMISSION INDUCTION; RISPERIDONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888368825     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.03.012     Document Type: Article

References (27)

1. Davidson, J.R., Meoni, P., Haudiquet, V., Cantillon, M., Hackett, D., 2002. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depression and Anxiety 16, 4-13.
2. Domschke, K., Deckert, J., Arolt, V., Baune, B.T., 2010. Anxious versus non-anxious depression: difference in treatment outcome. Journal of Psychopharmacology 24, 621-622.
3. Fang, Y., Yuan, C., Xu, Y., Chen, J., Wu, Z., Cao, L., Yi, Z., Hong, W., Wang, Y., Jiang, K., Gao, K., Cui, X., Nierenberg, A.A., 2010. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. Journal of Clinical Psychopharmacology 30, 357-364.
4. Fang, Y., Yuan, C., Xu, Y., Chen, J., Wu, Z., Cao, L., Yi, Z., Hong, W., Wang, Y., Jiang, K., Cui, X., Calabrese, J.R., Gao, K., 2011. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. Journal of Clinical Psychopharmacology 31, 638-642.
5. Fava, M., Uebelacker, L.A., Alpert, J.E., Nierenberg, A.A., Pava, J.A., Rosenbaum, J.F., 1997. Major depressive subtypes and treatment response. Biological Psychiatry 42, 568-576.
6. Fava, M., Alpert, J.E., Carmin, C.N., Wisniewski, S.R., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., Morgan, D., Schwartz, T., Balasubramani, G.K., Rush, A.J., 2004. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine 34, 1299-1308.
7. Fava, M., Rush, A.J., Alpert, J.E., Carmin, C.N., Balasubramani, G.K., Wisniewski, S.R., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., 2006. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Canadian Journal of Psychiatry 51, 823-835.
8. Fava, M., Rush, A.J., Alpert, J.E., Balasubramani, G.K., Wisniewski, S.R., Carmin, C.N., Biggs, M.M., Zisook, S., Leuchter, A., Howland, R., Warden, D., Trivedi, M.H., 2008. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342-351.
9. Flint, A.J., Rifat, S.L., 1997. Anxious depression in elderly patients. Response to antidepressant treatment. American Journal of Geriatric Psychiatry 5, 107-115.
10. Gaynes, B.N., Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Balasubramani, G.K., Spencer, D.C., Petersen, T., Klinkman, M., Warden, D., Nicholas, L., Fava, M., 2007. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Annals of Family Medicine 5, 126-134.
11. Hamilton, M., 1960. A rating scale for depression. Journal of Neurology, Neurosur-gery, and Psychiatry 23, 56-62.
12. Howland, R.H., Rush, A.J., Wisniewski, S.R., Trivedi, M.H., Warden, D., Fava, M., Davis, L.L., Balasubramani, G.K., McGrath, P.J., Berman, S.R., 2009. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug and Alcohol Dependence 99, 248-260.
13. Nelson, J.C., Delucchi, K., Schneider, L.S., 2008. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. American Journal of Geriatric Psychiatry 16, 558-567.
14. Nelson, J.C., Delucchi, K., Schneider, L.S., 2009. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis. International Journal of Geriatric Psychiatry 24, 539-544.
15. Nelson, J.C., 2010. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depression and Anxiety 27, 12-18.
16. Papakostas, G.I., Trivedi, M.H., Alpert, J.E., Seifert, C.A., Krishen, A., Goodale, E.P., Tucker, V.L., 2008. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials. Journal of Psychiatric Research. 42, 134-140.
17. Parker, G., Gladstone, G., Chee, K.T., 2001. Depression in the planet's largest ethnic group: the Chinese. American Journal of Psychiatry 158, 857-864.
18. Regier, D.A., Rae, D.S., Narrow, W.E., Kaelber, C.T., Schatzberg, A.F., 1998. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of PsychiatrySupplement, 24-28.
19. Rush, A.J., Zimmerman, M., Wisniewski, S.R., Fava, M., Hollon, S.D., Warden, D., Biggs, M.M., Shores-Wilson, K., Shelton, R.C., Luther, J.F., Thomas, B., Trivedi, M.H., 2005. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. Journal of Affective Disorders 87, 43-55.
20. Shi, S., Zhang, M., Wu, W., Lu, Z., Zhou, T., Zhang, H., Liu, Y., Zhao, J., Sun, X., Li, M., Zhang, N., Liu, S., Tao, M., Li, H., Yang, Y., Wei, J., Ji, J., Zhao, B., Chen, S., Qu, Z., 2009. Multi-center study of the clinical features in depression comorbidity with anxiety disorders. Shanghai Archives of Psychiatry 21, 198-202.
21. Silverstone, P.H., von Studnitz, E., 2003. Defining anxious depression: going beyond comorbidity. Canadian Journal of Psychiatry 48, 675-680.
22. Thase, M.E., Rush, A.J., 1997. When at first you don't succeed: sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry 58 (Suppl. 13), 23-29.
23. Thase, M.E., 2004. Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence. CNS Spectrum 9 (808-816), 818-821.
24. Tollefson, G.D., Holman, S.L., Sayler, M.E., Potvin, J.H., 1994. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. Journal of Clinical Psychiatry 55, 50-59.
25. Uher, R., Dernovsek, M.Z., Mors, O., Hauser, J., Souery, D., Zobel, A., Maier, W., Henigsberg, N., Kalember, P., Rietschel, M., Placentino, A., Mendlewicz, J., Aitchison, K.J., McGuffin, P., Farmer, A., 2011. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nor-triptyline. Journal of Affective Disorders 132, 112-120.
26. Wu, Z., Chen, J., Yuan, C., Han, Y., Tao, M., Zheng, H., Zhang, F., Guo, T., Lv, Y., Xie, S., Wang, Y., Hong, W., Yi, Z., Fang, Y., 2010. Clinical characteristics of treatment-resistant depression with and without anxious features. Chinese Journal of Psychiatry 43, 196-200.
27. Zheng, Y.P., Zhao, J.P., Phillips, M., Liu, J.B., Cai, M.F., Sun, S.Q., Huang, M.F., 1988. Validity and reliability of the Chinese Hamilton Depression Rating Scale. British Journal of Psychiatry 152, 660-664.